The second ‘Exchange of Experts’ programme for European Neighbourhood Policy partner countries took place on 29 – 30 May 2023 with Greece and Lebanon and focused on Legionnaires’ disease.
In the framework of the EU Initiative on Health Security, ECDC and the EU Member States set up an ‘Exchange of Experts’ programme aiming to provide experts from European Neighbourhood Policy (ENP) partner countries with opportunities to learn from the experiences of EU Member States within specific disease areas, and in turn, share their own experiences.
ECDC and EMA have issued a joint statement on adapted COVID-19 vaccines and considerations for their use during the upcoming autumn 2023 vaccination campaigns.
EU/EEA countries are reporting an increased number of Escherichia coli (E. coli) isolates carrying the blaNDM-5 gene that makes them resistant to carbapenems, antibiotics.
Between 2018 and 2020, nearly 20 000 surgical site infections (SSIs) were reported from a total of over 1.2 million surgical procedures in 13 EU/EEA countries participating in ECDC-coordinated SSI surveillance. Over 2 500 hospitals are part of this surveillance network.
ECDC presents lessons learned from the response of Europe’s public health sector to the pandemic and highlights follow up actions addressing relevant issues which could improve Europe’s pandemic preparedness.
To decrease the impact of COVID-19, and related hospitalisations and mortality, countries should plan for a continued roll-out of COVID vaccines in 2023.
Since late February 2023 and up until 30 March 2023, 87 cases of botulism linked to intragastric injection of the botulinum neurotoxin (BoNT) have been reported.
Since June 2017, a persistent cross-border outbreak of Salmonella Virchow ST16 has been ongoing in five EU/EEA countries, the UK, and the US, according to a Rapid Outbreak Assessment released by ECDC and EFSA today.